Christopher Liu is a Director at Leerink Partners, based in the United States. He has been with the firm since February 2023. Prior to his current role, Christopher served as Vice President, Equity Research, Biotechnology at Leerink Partners from February 2022 to February 2023.

Before joining Leerink Partners, he held the same title at SVB Leerink from April 2020 to February 2022. Christopher also worked as a Senior Biotechnology Equity Research Associate at Canaccord Genuity LLC from September 2018 to April 2020.

Earlier in his career, he was an Equity Research Associate at Oppenheimer & Co. Inc. and a Healthcare Investment Intern at Venrock. Christopher began his professional journey as a Healthcare Consulting Intern at EisnerAmper LLP and a Research Assistant at Rutgers University.